Literature DB >> 24666419

Bilevel positive airway pressure for obstructive sleep apnea.

Meghna P Mansukhani1, Bhanu Prakash Kolla, Eric J Olson, Kannan Ramar, Timothy I Morgenthaler.   

Abstract

For most patients with obstructive sleep apnea syndrome (OSA), continuous positive airway pressure (CPAP) is an effective therapy. However, for a subset of individuals, CPAP is either not effective or is poorly tolerated. Bilevel positive airway pressure (BPAP) is potentially capable of treating OSA at a lower mean pressure than CPAP and can help augment ventilation via pressure support. This review summarizes the evidence for the use of BPAP in spontaneous mode in the initial treatment of patients with OSA and in those who are poorly compliant with CPAP therapy. It also examines evidence regarding use of BPAP in OSA with associated hypoventilation, such as in chronic obstructive pulmonary disease or severe obesity. Finally, current clinical guidelines that help determine which patients would be candidates for a BPAP device and how to manually titrate BPAP to determine the optimal settings to be prescribed are also discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24666419     DOI: 10.1586/17434440.2014.900435

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  3 in total

1.  Auto-trilevel versus bilevel positive airway pressure ventilation for hypercapnic overlap syndrome patients.

Authors:  Mei Su; Juan Cao; Ding Ning; Rong Xue; Meijie Xu; Mao Huang; Xilong Zhang
Journal:  Sleep Breath       Date:  2017-06-13       Impact factor: 2.816

Review 2.  Obstructive sleep apnoea syndrome and its management.

Authors:  Lucia Spicuzza; Daniela Caruso; Giuseppe Di Maria
Journal:  Ther Adv Chronic Dis       Date:  2015-09       Impact factor: 5.091

3.  Combined surgical treatment for severe sleep apnoea, to improve BiPAP compliance.

Authors:  Yeşim Başal; Utku Oğan Akyıldız; Aylin Eryilmaz
Journal:  BMJ Case Rep       Date:  2015-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.